Work

Abstract B006: Qualitative research study on the use of minimal residual disease as an intermediate endpoint in multiple myeloma clinical trials in Saudi Arabia

Year: 2024

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.liqbiop24-b006

Authors: Albandari A Alnasser, Tariq H Alqurayshah

Institution: Saudi Food and Drug Authority

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404305859

Cites:

Cited by:

Related to: 10